BlackRock’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $365M | Sell |
|
|||||
|
2025
Q1 | $396M | Sell |
|
|||||
|
2024
Q4 | $357M | Sell |
|
|||||
|
2024
Q3 | $296M | Buy |
|
|||||
|
2024
Q2 | $238M | Buy |
|
|||||
|
2024
Q1 | $220M | Sell |
|
|||||
|
2023
Q4 | $210M | Buy |
|
|||||
|
2023
Q3 | $155M | Buy |
|
|||||
|
2023
Q2 | $279M | Buy |
|
|||||
|
2023
Q1 | $304M | Sell |
|
|||||
|
2022
Q4 | $251M | Buy |
|
|||||
|
2022
Q3 | $307M | Buy |
|
|||||
|
2022
Q2 | $239M | Sell |
|
|||||
|
2022
Q1 | $233M | Sell |
|
|||||
|
2021
Q4 | $255M | Sell |
|
|||||
|
2021
Q3 | $242M | Sell |
|
|||||
|
2021
Q2 | $276M | Buy |
|
|||||
|
2021
Q1 | $294M | Buy |
|
|||||
|
2020
Q4 | $368M | Buy |
|
|||||
|
2020
Q3 | $268M | Buy |
|
|||||
|
2020
Q2 | $288M | Buy |
|
|||||
|
2020
Q1 | $229M | Buy |
|
|||||
|
2019
Q4 | $236M | Buy |
|
|||||
|
2019
Q3 | $159M | Buy |
|
|||||
|
2019
Q2 | $203M | Buy |
|
|||||
|
2019
Q1 | $155M | Buy |
|
|||||
|
2018
Q4 | $127M | Buy |
|
|||||
|
2018
Q3 | $171M | Buy |
|
|||||
|
2018
Q2 | $116M | Buy |
|
|||||
|
2018
Q1 | $88.8M | Buy |
|
|||||
|
2017
Q4 | $51.6M | Sell |
|
|||||
|
2017
Q3 | $62.9M | Buy |
|
|||||
|
2017
Q2 | $57.5M | Sell |
|
|||||
|
2017
Q1 | $32.1M | Buy |
|
|||||
|
2016
Q4 | $557K | Sell |
|
|||||
|
2016
Q3 | $816K | Buy |
|
|||||
|
2016
Q2 | $406K | Buy |
|
|||||
|
2016
Q1 | $315K | Buy |
|
|||||
|
2015
Q4 | $33K | Sell |
|
|||||
|
2015
Q3 | $597K | Buy |
|
|||||
|
2015
Q2 | $1.06M | Buy |
|
|||||
|
2015
Q1 | $40K | Sell |
|
|||||
|
2014
Q4 | $39K | Buy |
|
|||||
|
2014
Q3 | $23K | Hold |
|
|||||
|
2014
Q2 | $14K | Buy |
|
|||||
|
2014
Q1 | $8K | Hold |
|
|||||
|
2013
Q4 | $5K | Buy |
|
|||||
|
2013
Q3 | $4K | Buy |
|